Nrf2抑制剂布鲁萨托尔促进人类骨髓瘤 (MG63) 的生长,并阻断EB1089诱导的分化
Emily Stephens1, Alexander Greenhough1, Jason P Mansell1
1School of Applied Sciences, University of the West of England, Coldharbour Lane, Bristol BS16 1QY, UK.
International journal of molecular sciences
|October 16, 2025
概括
布鲁萨托尔是一种Nrf2抑制剂,意外地促进了骨髓瘤细胞的生长,并在体外抑制了分化. 这表明布鲁萨托尔可能不是适合治疗骨髓瘤的治疗药物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 几十年来,转移性骨肉瘤 (OS) 的存活率停滞不前,需要新的治疗策略.
- 核因子红色素2相关因子2 (Nrf2) 与OS中化学放射治疗耐药性有关.
- 布鲁萨托尔 (Bru) 是一种天然的Nrf2抑制剂,在各种瘤模型中表现出抗癌作用.
研究的目的:
- 为了研究布鲁萨托尔 (Bru) 作为骨髓瘤 (OS) 的潜在治疗剂的疗效.
- 评估Nrf2抑制对OS细胞生长和分化的影响.
主要方法:
- 在正常和缺氧条件下利用人类骨髓瘤细胞系MG63.
- 用布鲁萨托尔 (50nM) 进行3天的治疗,以评估其对细胞增殖的影响.
- 研究了布鲁萨托尔在与EB1089和溶酸联合治疗时对MG63分化的影响.
- 评估了使用二甲基烟酸激活Nrf2的作用.
主要成果:
- 布鲁萨托尔在正常 (1.7倍增加) 和缺氧 (1.3倍增加) 条件下显著促进MG63细胞生长.
- 布鲁萨托尔严重抑制了由EB1089和溶酸诱导的MG63分化 (2.8倍抑制).
- Nrf2激活剂,二甲基烟酸,没有逆转观察到的表型.
结论:
- 与预期相反,布鲁萨托尔在MG63骨髓瘤细胞系中表现出促生殖和抗分化作用.
- 这些发现表明,布鲁萨托尔可能不是适合治疗骨髓瘤的候选药物.
- 需要进一步的研究,以了解布鲁萨托尔在OS中的悖论性作用背后的具体机制.
关键词:
在EB1089中,你会看到EB1089的位置.Nrf2 没有任何问题.性酸酶是一种性性酸酶.布鲁萨托尔 (Brusatol) 是一种制剂.不同化的差异化差异化.增长的增长增长的增长增长的增长.缺氧 缺氧是指缺氧的情况.骨质肉瘤是骨质肉瘤的一种疾病.更多相关视频
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11.2K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
14.2K
相关概念视频
02:26NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K